Accueil/SYK

Public research page

Market data comes from the live feed. The company research below uses verified public sources, but it is not a real-time personalized AI conclusion.

Analyze SYK in workspace
SYKNYSE/health care

Stryker Corporation

$331.45Up+1,67 (+0,51%)
Research reviewed: 12 juil. 2026, 00:00 UTC
Research overview3-month price contextInvestment thesisKey catalystsLatest earnings researchRecent newsData and research sources

Research overview

Stryker Corporation operates in Health Care Equipment within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

Ouverture
330,18
Haut
335,96
Bas
329,10
Capitalisation
127,06 Md
Ratio C/B
38.36
Plus haut sur 52 semaines
--
Dividende
1.070%
Dividende trimestriel
--

3-month price context

Le graphique présente la tendance récente sur 3 mois afin de comprendre la structure court terme avant d’ouvrir le workspace complet.

Investment thesis

Base case
Robotic placements can pull through implants, disposables and service revenue while deepening surgeon adoption. The base case remains conditional on supply and manufacturing staying manageable.
Bull case
Robotic placements can pull through implants, disposables and service revenue while deepening surgeon adoption. Healthy elective procedure volumes can sustain demand across hips, knees, trauma and surgical equipment. New implants, neurovascular tools and operating-room technologies can extend share gains.
Bear case
Component shortages, quality issues or sterilization constraints could disrupt high-demand product availability. Budget pressure can delay purchases of robots, beds and other capital equipment. Frequent portfolio additions can raise integration, valuation and management-attention risk.

Key catalysts

  • Mako installed base

    Robotic placements can pull through implants, disposables and service revenue while deepening surgeon adoption.

  • Procedure growth

    Healthy elective procedure volumes can sustain demand across hips, knees, trauma and surgical equipment.

  • Product innovation

    New implants, neurovascular tools and operating-room technologies can extend share gains.

Principal risks

  • Supply and manufacturing

    Component shortages, quality issues or sterilization constraints could disrupt high-demand product availability.

  • Hospital capital budgets

    Budget pressure can delay purchases of robots, beds and other capital equipment.

  • Acquisition execution

    Frequent portfolio additions can raise integration, valuation and management-attention risk.

Latest earnings research

Q1 2026

Stryker's first-quarter 2026 results reflected continued demand across MedSurg, Neurotechnology and Orthopaedics, supported by procedure volumes, capital equipment and product innovation.

Valuation interpretation

  • The installed-base model supports premium quality when robotic placements translate into recurring implant and service pull-through.
  • Procedure resilience should be assessed alongside hospital capital cycles and ongoing acquisition requirements.

Peer research

ABTBSXISRG

Recent news

Zacks · il y a 3 jours

ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?

Simply Wall St. · il y a 4 jours

Stryker (SYK) Stock Loses Russell Growth Slots As Active Investors Step In

Barchart · il y a 4 jours

Stryker's Quarterly Earnings Preview: What You Need to Know

Insider Monkey · il y a 4 jours

Mixed Drivers Fuel Optimism in Stryker Corporation’s (SYK) Performance

Trefis · il y a 5 jours

The Wide Chasm Priced Into Boston Scientific Stock

Continue in the research workspace

Keep SYK in context, run a multi-agent analysis, and monitor thesis changes.

Analyze SYK free

Explorer tout le système de recherche

Chaque étape remplit une mission précise et produit un résultat vérifiable.

Méthodologie de rechercheLire les rapports de marché
Thesis invalidation
Reassess the thesis if component shortages, quality issues or sterilization constraints could disrupt high-demand product availability.

Trefis · il y a 5 jours

Just How Much Risk Is Built Into ISRG Stock?

Data and research sources

Research updated: 12 juil. 2026, 00:00 UTC
3 verified sources
First Quarter 2026 Operating ResultsStryker Corporation · earningsVerified

Fetched: 12/07/2026 0:00:00 UTC

Published: 30/04/2026 00:00:00

Open original source
Stryker Corporation Investor RelationsStryker Corporation · companyVerified

Fetched: 12/07/2026 0:00:00 UTC

Open original source
Stryker SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 12/07/2026 0:00:00 UTC

Published: 30/04/2026 00:00:00

Open original source
Explorer les actions

Continue researching this stock

Analyste de Marché

Analyste de Marché se concentre sur l’étape Observer au sein de Recherche centrale et prépare le terrain pour les rôles suivants.

Analyste Fondamental

Analyste Fondamental se concentre sur l’étape Observer au sein de Recherche centrale et prépare le terrain pour les rôles suivants.

Analyste Actualités

Analyste Actualités se concentre sur l’étape Observer au sein de Recherche centrale et prépare le terrain pour les rôles suivants.

Responsable Risque

Responsable Risque se concentre sur l’étape Surveiller au sein de Risque et suivi et prépare le terrain pour les rôles suivants.